Biotech ETFs have become a popular tool for investors looking to enhance return opportunities through a tactical allocation within their portfolio, thanks in large part to a blistering track record. Biotech ETFs can be found near the top of most performance leaderboards over both five-year and 10-year time horizons, having outperformed broad-based funds by a wide margin in recent years. Continue reading →
